From 18th, October, 2010, Celnovte has passed for ten years and achieved for great achievement. We provide IVD products, all- round services and total solutions. Now we have built five R&D and product platforms including tumor immunohistochemical antibody products, tumor molecular pathological diagnosis products, tumor histopathological staining products, tuberculosis culture and drug sensitivity identification products and genetic disease and prenatal diagnosis products.
In 2020, Celnovte Biotechnology has already established 2000 square meters 10,000 and 100,000 class cleaning-room and 5000 square meters new production base. Celnovte Biotechnology has a strong innovation ability. We have launched MicroStacker detection system by our U.S. R&D team. Also, we have over 60 primary antibodies developed by ourselves. We have launched international market in ASEAN countries and will have a worldwide reach.
Congradulations to ten successful years of Celnovte Biotechnology!
Contact us info@celnovte-bio-tech.com